To get new results, you need to look at new tools. Artificial intelligence (AI) and machine learning unlock new insights from a widening pool of data sources, helping you
IQVIA is uniquely positioned to help connect research with commercialization, so you can optimize your drug development strategy and focus your investment on the most promising compounds.
Because we don’t just deliver market data, we leverage the latest technology, advance analytics and healthcare knowledge to generate insights that enable excellence in execution from molecule to market.
The IQVIA CORE puts IQVIA's unique, integrated capabilities at your fingertips. Our team of consultants is dedicated to healthcare and can count on the domain expertise of +1,100 medical doctors and +1,400 PhDs. Our unparalleled 35 petabytes of unique data together with the application of advanced analytics, powered by AI and machine learning, can provide you with the insights needed to make more informed decisions.
Access new resources for advanced therapy development, from candidate identification through market authorization.
Build and compare potential pipeline development strategies quickly and transparently.
Capture the patient experience across the full trial process, from strategy to dissemination of results.
Use machine learning-driven analytics to help identify promising patient subgroups, potentially preserving your investment and ensuring valuable therapies reach patients.
Understand how payers, providers, and patients define value, and accelerate market access for new and innovative products.
Strengthen your portfolio by making more informed decisions and fewer assumptions, and prepare for the impact of new research discoveries and events.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Learn how unparalleled data, domain expertise, and technologies enable AI-powered solutions that are purpose-built for healthcare.